Botensilimab and balstilimab in metastatic pretreated MSSCRC

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=ZJ4Sef7FKqc

Benjamin Schlechter, MD, Dana-Farber Cancer Institute, Boston, MA, presents expanded data from the microsatellite stable colorectal (MSS-CRC) expansion cohor...

Speaker: Benjamin Schlechter, Institution: Dana-Farber Cancer Institute, Event: ASCO GI 2023, Format: Interview, Subject: Gastrointestinal Cancer, Subject: Colorectal Cancer, Field: Treatment, Field: Trial Updates, Field: Immuno-Oncology, Medicines: Botensilimab, Medicines: Balstilimab, NCT03860272, Medicines: Antibodies
#############################